TRCT
SWAV

Tower Research Capital (TRC)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Tower Research Capital (TRC)’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,739
Closed -$566K – 6127
2024
Q1 		$566K Sell
1,739
-4,676
-73% -$1.15M 0.01% 797
2023
Q4 		$1.22M Buy
6,415
+753
+13% +$142K 0.02% 741
2023
Q3 		$1.13M Buy
5,662
+3,339
+144% +$790K 0.04% 488
2023
Q2 		$663K Buy
2,323
+667
+40% +$185K 0.02% 787
2023
Q1 		$359K Buy
1,656
+239
+17% +$46.6K 0.01% 1030
2022
Q4 		$291K Sell
1,417
-1,951
-58% -$493K 0.01% 1042
2022
Q3 		$937K Sell
3,368
-5,652
-63% -$1.44M 0.02% 733
2022
Q2 		$1.72M Buy
9,020
+6,722
+293% +$1.19M 0.04% 421
2022
Q1 		$477K Sell
2,298
-103
-4% -$17K ﹤0.01% 1179
2021
Q4 		$428K Buy
2,401
+1,486
+162% +$293K 0.01% 1219
2021
Q3 		$188K Buy
915
+200
+28% +$39.3K ﹤0.01% 1880
2021
Q2 		$136K Sell
715
-2,116
-75% -$346K ﹤0.01% 2181
2021
Q1 		$369K Buy
2,831
+1,114
+65% +$134K 0.01% 1488
2020
Q4 		$178K Sell
1,717
-22,589
-93% -$1.96M 0.01% 1813
2020
Q3 		$1.84M Buy
24,306
+20,779
+589% +$1.18M 0.02% 448
2020
Q2 		$167K Buy
3,527
+3,444
+4,149% +$142K 0.01% 1964
2020
Q1 		$3K Buy
+83
New +$3.3K ﹤0.01% 2512
2019
Q4 		– Sell
-230
Closed -$7K – 4552
2019
Q3 		$7K Buy
+230
New +$9.77K ﹤0.01% 3167
2019
Q2 		– Sell
-453
Closed -$15K – 4448
2019
Q1 		$15K Buy
+453
New +$15K ﹤0.01% 2454

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Tower Research Capital (TRC)'s SWAV Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,739 shares — an estimated $566K sold.

Tower Research Capital (TRC) first reported a position in SWAV in Q1 2019 and held it in 19 quarters. The position peaked at $1.84M in Q3 2020. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,739 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $566K.
  • Tower Research Capital (TRC) first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 19 quarters.
  • Tower Research Capital (TRC)'s Shockwave Medical, Inc. Common Stock position peaked at $1.84M in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.